Therapy forms for advanced heart failure. Heart transplantation

被引:0
|
作者
Fernandes, L. Kopp [1 ]
Hummel, M. [1 ]
Knosalla, C. [1 ]
Schoenrath, F. [1 ]
机构
[1] Deutsch Herzzentrum Berlin, Klin Herz, Thorax & Gefasschirurg, Augustenburger Pl 1, D-13353 Berlin, Germany
来源
KARDIOLOGE | 2016年 / 10卷 / 04期
关键词
Heart failure; Allocation; Complications; Aftercare; Survival;
D O I
10.1007/s12181-016-0063-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart transplantation is the gold standard for end stage heart failure and the only long-term therapy at this stage of the disease. To achieve long-term survival following heart transplantation careful preoperative somatic and psychological evaluation ismandatory. Organ allocation in Germany is operated by Eurotransplant (The Netherlands). Due to a shortage of donor organs, most organs are allocated to recipients with a highly urgent status. After successful transplantation it is of paramount importance in the aftercare to identify and treat possible cardiac allograft vasculopathy, infections, malignancies and organ rejection. A cornerstone for this is modern differentiated immunosuppressive therapy.
引用
收藏
页码:249 / 257
页数:9
相关论文
共 50 条
  • [1] Therapy forms for advanced heart failure. Ventricular assist devices
    Pergantis, P.
    Krabatsch, T.
    Potapov, E.
    Schoenrath, F.
    [J]. KARDIOLOGE, 2016, 10 (02): : 119 - 128
  • [2] Cardiac resynchronisation therapy in patients with advanced congestive heart failure.
    Sterliñski, M
    Jankowska, A
    Pytkowski, M
    Malczewska, B
    Firek, B
    Maciag, A
    Przybylski, A
    Szwed, H
    [J]. ACTA CARDIOLOGICA, 2004, 59 (02) : 236 - 237
  • [3] Hormone replacement therapy predicts outcome in women with advanced heart failure.
    Lindenfeld, J
    Ghali, JK
    Krause-Steinrauf, HJ
    Thaneemit-Chen, S
    Larsen, RL
    Lowes, BD
    Rosenberg, YD
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 213A - 213A
  • [4] Cell therapy in congestive heart failure.
    Tao Z.W.
    Li L.G.
    [J]. Journal of Zhejiang University SCIENCE B, 2007, 8 (9): : 647 - 660
  • [5] Heart transplantation as a treatment for advanced heart failure
    Morán, S
    Castro, P
    Zalaquett, R
    Becker, P
    Garayar, B
    Irarrázaval, MJ
    Jalil, J
    Lema, G
    Fajuri, A
    Pérez, O
    Martínez, A
    Marchant, E
    Chamorro, G
    [J]. REVISTA MEDICA DE CHILE, 2001, 129 (01) : 9 - 17
  • [6] Current status of heart transplantation as therapy for advanced heart failure in African Americans
    Higgins, R. S. D.
    Edwards, L. L.
    Okum, E. J.
    Mullen, G. M.
    Dunlap, S. H.
    Hauptman, P. J.
    Pagani, F. D.
    Aaronson, K. D.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : S75 - S75
  • [7] Cardiac transplantation does not correct neurohormonal aberration in patients with advanced heart failure.
    Najman, DM
    Sica, D
    Cusick, DA
    Roberge, P
    Quigg, RJ
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (07) : A400 - A400
  • [8] The economic outcome of heart transplantation versus medical therapy of advanced heart failure patients
    Yajnik, M.
    Vaidya, V.
    Kawano, M.
    Ankrom, A.
    Hamilton, M.
    Kobashigawa, J.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 215 - 215
  • [9] Safety and Efficacy of Semaglutide Therapy in Advanced Heart Failure Patients Awaiting Heart Transplantation
    Poglajen, G.
    Frljak, S.
    Zemljic, G.
    Cerar, A.
    Knezevic, I.
    Vrtovec, B.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S503 - S503
  • [10] Management of Advanced Heart Failure The Role of Heart Transplantation
    Kittleson, Michelle M.
    Kobashigawa, Jon A.
    [J]. CIRCULATION, 2011, 123 (14) : 1569 - 1574